Kings Point Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$14K Hold
62
﹤0.01% 541
2021
Q4
$17K Hold
62
﹤0.01% 573
2021
Q3
$15K Hold
62
﹤0.01% 521
2021
Q2
$15K Hold
62
﹤0.01% 494
2021
Q1
$14K Buy
+62
New +$12.4K ﹤0.01% 496

Other funds holding LH

Kings Point Capital Management's LH Position: Q1 2022 in Review

Kings Point Capital Management held its Labcorp (LH) position steady in Q1 2022 at 62 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #541.

Kings Point Capital Management first reported a position in LH in Q1 2021 and has held it in 5 quarters since. The position peaked at $17K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Kings Point Capital Management held 62 shares of Labcorp worth $14K as of Q1 2022.
  • Kings Point Capital Management left its Labcorp share count unchanged in Q1 2022.
  • Labcorp made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #541 holding.
  • Kings Point Capital Management first reported a position in Labcorp in Q1 2021 and has held it in 5 quarters since.
  • Kings Point Capital Management's Labcorp position peaked at $17K in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.